Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Income towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesResearch & DevelopmentShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Intelligent Bio Solutions (INBS) Cost of Revenue (2022 - 2025)

Intelligent Bio Solutions has reported Cost of Revenue over the past 3 years, most recently at $645311.0 for Q1 2024.

  • For Q1 2024, Cost of Revenue rose 52.19% year-over-year to $645311.0; the TTM value through Mar 2024 reached $2.2 million, changed N/A, while the annual FY2023 figure was $930204.0, N/A changed from the prior year.
  • Cost of Revenue for Q1 2024 was $645311.0 at Intelligent Bio Solutions, up from $564815.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $645311.0 in Q1 2024 and troughed at $112635.0 in Q4 2022.
  • A 3-year average of $450682.2 and a median of $493886.0 in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: surged 401.46% in 2023 and later soared 52.19% in 2024.
  • Year by year, Cost of Revenue stood at $112635.0 in 2022, then surged by 401.46% to $564815.0 in 2023, then grew by 14.25% to $645311.0 in 2024.
  • Business Quant data shows Cost of Revenue for INBS at $645311.0 in Q1 2024, $564815.0 in Q4 2023, and $563763.0 in Q3 2023.